Home › Follicular Lymphoma › Washington › Seattle
Pag-aaral pangklinika para sa Follicular Lymphoma sa Seattle, WA
16 pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Seattle (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Nagre-recruitPhase 1/2
- Research Site, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- Swedish Cancer Institute (SCI), Seattle
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Nagre-recruitPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
- Swedish Medical Center-First Hill, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Nagre-recruitPhase 3
- Fred Hutch Cancer Center, Seattle
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
Nagre-recruitPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
- Fred Hutchinson Cancer Center, Seattle
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
Nagre-recruitPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- Fred Hutchinson Cancer Center, Seattle
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
Nagre-recruitPhase 1/2
- University of Washington-Seattle Cancer Care Alliance, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Nagre-recruitPhase 1
- Swedish Cancer Institute, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Nagre-recruit
- University of Washington Medical Center, Seattle
Pag-aaral para sa Follicular Lymphoma sa ibang lungsod
- New York City, NY24 pag-aaral
- Milwaukee, WI19 pag-aaral
- Nashville, TN18 pag-aaral
- Houston, TX18 pag-aaral
- Boston, MA17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Durham, NC15 pag-aaral
- Columbus, OH14 pag-aaral
- Salt Lake City, UT12 pag-aaral
- Philadelphia, PA12 pag-aaral
- San Antonio, TX12 pag-aaral
- Chicago, IL12 pag-aaral
Iba pang pag-aaral sa Seattle
- Non-Small Cell Lung Cancer53 pag-aaral
- Kanser (lahat ng uri)50 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Kanser sa Suso40 pag-aaral
- Metastatic Cancer39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Kanser sa Baga33 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Pancreas22 pag-aaral
- Multiple Myeloma22 pag-aaral
- Acute Lymphoblastic Leukemia21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.